Uhrhan T, Schaefer M
Charité Universitätsmedizin, Wörther Str. 4, 10435, Berlin, Deutschland.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2010 May;53(5):451-9. doi: 10.1007/s00103-010-1053-8.
Nursing home residents are a continuously growing population with a need for intense pharmacotherapy due to numerous comorbid conditions. Polypharmacy and the frequent use of psychotropic medication increase the risk of adverse drug events, which may result in risk of increased morbidity and mortality in frail, elderly patients. The requirement to solve individual therapeutic problems has to be supported by not only an adequate and need-based pharmaceutical supply but also by suitable organizational and logistic solutions. In the nursing home environment, ineffective communication between the various professional groups involved in medical treatment may lead to inappropriate or unintentional medication use. In the present survey, data and research results that are relevant to assess the medical treatment situation in long-term care facilities particularly with regard to the safety of pharmacotherapy are presented. The two problem areas of patient-customized therapy and the handling of pharmaceuticals in the context of institutional care are addressed separately.
养老院居民数量持续增长,由于多种合并症,他们需要强化药物治疗。多重用药以及精神药物的频繁使用增加了药物不良事件的风险,这可能导致体弱的老年患者发病率和死亡率上升。解决个体治疗问题不仅需要充足且基于需求的药品供应,还需要合适的组织和后勤解决方案。在养老院环境中,参与医疗的各个专业群体之间沟通不畅可能导致用药不当或无意用药。在本次调查中,呈现了与评估长期护理机构医疗状况相关的数据和研究结果,特别是关于药物治疗安全性的内容。患者定制治疗和机构护理背景下药品处理这两个问题领域将分别进行探讨。